YAMAGATA UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1878-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.yamagata-u.ac.jp/
Clinical Trials
17
Active:0
Completed:5
Trial Phases
2 Phases
Phase 3:1
Not Applicable:15
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Not Applicable
15 (93.8%)Phase 3
1 (6.3%)Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma
Phase 3
- Conditions
- Metastatic Renal Cell Carcinoma
- Interventions
- Drug: Sorafenib-sunitinibDrug: Sunitinib-sorafenib
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Yamagata University
- Target Recruit Count
- 120
- Registration Number
- NCT01481870
- Locations
- 🇯🇵
Yamagata University Faculty of Medicine, Yamagata, Japan
News
No news found